Disclosure Panels Details Page
Head and Neck Cancers Panel - Disclosures as of 12/20/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| David Adelstein MD | Innogene Kalbiotech | None | None | None | ✔ |
| Douglas Adkins MD | None | Aduro Akrevia Cue Biopharma Merck & Co., Inc. Oncolys Biopharma Pfizer Inc. |
None | None | - |
| Yoshimi Anzai MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| David Brizel MD | None | Amgen Inc. | None | None | - |
| Jennifer Burns BS | None | None | None | None | - |
| Paul Busse MD, PhD | None | None | None | None | - |
| Jimmy Caudell MD, PhD | Varian Medical Systems, Inc. | Varian Medical Systems, Inc. | None | None | ✔ |
| Anthony Cmelak MD | None | None | None | None | - |
| A. Dimitrios Colevas MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP ATARA Biotherapeutics Bristol Myers Squibb CellSight Technologies, Inc. Cullinan Exelixis Inc. Innate Pharma Tessa Therapeutics |
ATARA Biotherapeutics IQVIA RDS, Inc. LOXO Oncology Pfizer Inc. PRA Health Sciences Rakuten Medical, Inc. |
None | None | ✔ |
| Susan Darlow PhD | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| David Eisele MD, FACS | None | None | None | None | ✔ |
| Moon Fenton MD, PhD | None | None | None | None | ✔ |
| Robert Foote MD, FACR, FASTRO | Hitachi, Ltd | Alliance for Proton Therapy American Board of Radiology Cancer Terminator Foundation |
None | Bionix-patent rights-royalties from sales|Elsevier-Text Book Senior Editor-Royalties|UpToDate-Royalties for Content on Esthesioneuroblatoma | ✔ |
| Maura Gillison MD, PhD | None | Bristol Myers Squibb EMD Serono Merck & Co., Inc. |
None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Robert Haddad MD | Bristol Myers Squibb Genentech, Inc. ISA THERAPEUTICS Kura Oncology, Inc. Merck & Co., Inc. NANOBIOTX Pfizer Inc. |
Bayer HealthCare Bristol Myers Squibb Eisai Inc. Genentech, Inc. glenmark GSK Immunomic therapeutics loxo Merck & Co., Inc. nanobiotix Pfizer Inc. |
None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Wesley Hicks, Jr. MD | None | None | None | None | - |
| Ying Hitchcock MD | None | Galena Biopharma, Inc. | None | None | - |
| Antonio Jimeno MD, PhD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Celldex Therapeutics Genocea HolyStone Iovance Merck & Co., Inc. Moderna Pfizer Inc. Roche Laboratories, Inc. SQZ |
None | None | None | ✔ |
| Sasan Karimi MD | NA | NA | NA | NA | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Debra Leizman MD | None | None | None | None | ✔ |
| Ellie Maghami MD, FACS | None | None | None | None | ✔ |
| Loren Mell MD | AstraZeneca Pharmaceuticals LP Merck & Co., Inc. |
Nanobiotix | None | None | - |
| Bharat Mittal MD | None | None | None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| David Pfister MD | AstraZeneca Pharmaceuticals LP Atara Bayer HealthCare Boehringer Ingelheim GmbH Bristol Myers Squibb Eisai Inc. Eli Lilly and Company Exelixis Inc. Genentech, Inc. GSK Hookipa Incyte Corporation Kura Oncology, Inc. MedImmune Inc. Meira Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Plexxikon Regeneron Pharmaceuticals, Inc. |
Bristol Myers Squibb Celgene Corporation Incyte Corporation Merck & Co., Inc. |
None | None | - |
| Harlan Pinto MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Leslie Ray PharmD | None | None | None | None | - |
| John Ridge MD, PhD, FACS | None | None | None | None | - |
| James Rocco MD, PhD | None | sanofi-aventis U.S. | None | None | - |
| Cristina Rodriguez MD | AstraZeneca Pharmaceuticals LP Ayala Pharmaceuticals Bristol Myers Squibb Merck & Co., Inc. Roche Laboratories, Inc. |
Ayala Pharmaceuticals Cue Pharmaceuticals |
None | None | ✔ |
| Jatin Shah MD, PhD | None | None | None | None | - |
| Sharon Spencer MD | None | None | None | None | - |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | - |
| Randal Weber MD | None | None | None | None | - |
| Gregory Weinstein MD | None | None | None | Olympus Corporation | - |
| Francis Worden MD | Bayer HealthCare Bristol Myers Squibb Eisai Inc. Exelixis Inc. IRX Kura Oncology, Inc. LOXO Merck & Co., Inc. Oragenics Pfizer Inc. Rakuten Soligenix |
CUE Eli Lilly and Company expert witness |
None | None | ✔ |
| Justine Yang Bruce MD | Kura Oncology, Inc. Merck & Co., Inc. Seattle Genetics, Inc. |
Bristol Myers Squibb Genzyme Corporation |
None | None | ✔ |
| Sue Yom MD, PhD | BioMimetix Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. |
None | None | Springer|Up To Date | ✔ |
| Weining Zhen MD | None | None | None | None | ✔ |